Skip to main content

Advertisement

Log in

Role of prostaglandin E2 on gastric ulcers induced by non-steroidal anti-inflammatory compounds (NOSAC)

  • Original Articles
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

We investigated the effect of indomethacin and aspirin on the prostaglandin E2 (PGE2) levels in rat gastric mucosa. In untreated controls, the PGE2 level was 1085 ± 80 ng/g in the fundic- and 2435 ± 339 ng/g in the antral mucosa; it was markedly reduced by indomethacin (6 or 20mg/kg) in a dose-related manner prior to the formation of gastric ulcers. Aspirin (200mg/kg) also decreased the mucosal PGE2 content. The simultaneous infusion of 5Μg/kg 16, 16-dimethyl PGE2 and 20 mg/kg indomethacin inhibited the formation of gastric ulcers. Our experimental results suggested that the indomethacin- or aspirin-induced gastric mucosal lesions are due to a deficiency of endogenous mucosal PGE2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carmichael HA, et al: Cimetidine and prostaglandin: evidence for different modes of action on the rat gastric mucosa. Gastroenterology 74: 540, 1978

    Google Scholar 

  2. Kauffman GL, et al: Prostaglandin and cimetidine inhibit the formation of ulcers produced by parenteral salicylate. Gastroenterology 75: 1099, 1978

    PubMed  CAS  Google Scholar 

  3. Whittle BJR: Inhibition of prostacyclin (PGI2) formation in the rat small intestine and gastric mucosa by the ulcerogen, indomethacin. Brit J Pharmacol 64: 438, 1978

    Google Scholar 

  4. Menguy R: Role of inhibition of gastric mucous secretion in phenomenon of gastric mucosal injury by indomethacin. Am J Dis 12: 862, 1967

    Article  CAS  Google Scholar 

  5. Silvoso GR, et al: Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 91: 517, 1979

    PubMed  CAS  Google Scholar 

  6. Johansson C, et al: Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology 78: 479, 1980

    PubMed  CAS  Google Scholar 

  7. Vane JR: Inhibition of prostaglandin synthetase as a mechanism of action for aspirin-like drugs. Nature 231:232, 1971

    CAS  Google Scholar 

  8. Kobayashi K, et al: Determination of prostaglandins and the effect of indomethacin on rat gastric mucosa. Tohoku J Exp Med, in press

  9. Carter DC, et al: The effect of locally administered prostaglandin 15 (R) 15 methyl-E2 methyl ester on gastric ulcer formation in the Shay rat preparation. Prostaglandins 5: 455, 1974

    Article  PubMed  CAS  Google Scholar 

  10. Lippman W: Inhibition of indomethacin-induced gastric ulceration in the rat perorally-administered synthetic and natural prostaglandin analogues. Prostaglandin?: 1, 1974

  11. Robert A: Prostaglandins and the digestive system. Prostaglandins 3: 255, 1977

    Google Scholar 

  12. Bolton JP, et al: Stimulation of mucus and nonparietal secretion by the E2 prostaglandin. Am J Dig Dis 23: 359, 1978

    Article  PubMed  CAS  Google Scholar 

  13. Fung WP, et al: Effect of prostaglandin 15 (R), 15 methyl ester on the gastric mucosa in patients with peptic ulceration-an endoscopic and histological study. Prostaglandins 5: 465, 1974

    Article  PubMed  CAS  Google Scholar 

  14. Chaudhury TK, et al: Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74: 58, 1978

    PubMed  CAS  Google Scholar 

  15. Cohen MM: 15-Methyl prostaglandin E2 protects gastric mucosal barrier, in “Adv Prostaglandin Thromboxane Res” Vol 2, by Samuelsson B, Paoletti R. Raven Press, New York, 1976, p 937

    Google Scholar 

  16. Garner A, et al: Stimulation of alkaline secretion in amphibian-isolated gastric mucosa by 16, 16-dimethyl PGE2 and PGF. Gastroenterology 76: 497, 1979

    PubMed  CAS  Google Scholar 

  17. Ferguson WW, et al: Protective effect of prostaglandin E1 (PGE1) on lysosomal enzyme release in serotonin-induced gastric ulceration. Ann Surg 177: 648, 1973

    Article  PubMed  CAS  Google Scholar 

  18. Robert A, et al: Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins, in “Adv Prostaglandin Thromboxane Res” Vol 2, by Samuelsson B, Paoletti R. Raven Press, New York, 1976, p 507

    Google Scholar 

  19. Karim SMM, et al: Effect of some naturally occurring prostaglandins and synthetic analogues on gastric secretion and ulcer healing in man, in “Adv Prostaglandin Thromboxane Res” Vol 2, by Samuelsson B, Paoletti R. Raven Press, New York, 1976, p 529

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobayashi, K., Arakawa, T., Nakamura, H. et al. Role of prostaglandin E2 on gastric ulcers induced by non-steroidal anti-inflammatory compounds (NOSAC). Gastroenterol Jpn 16, 600–603 (1981). https://doi.org/10.1007/BF02813795

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02813795

Key Words

Navigation